Systemic chronic beryllium disease: beyond lung disease.

Authors

Louis Jouanjan, Gernot Zissel, Prerana Agarwal, Daiana Stolz, Björn Christian Frye

Published in

Occupational and environmental medicine. Jul 30, 2026. Epub Jul 30, 2026.

Abstract

Systemic involvement in chronic beryllium disease (CBD) has been reported only anecdotally.
We describe a case series of six patients with CBD demonstrating systemic involvement across diverse occupational settings.
All patients had documented occupational beryllium exposure. CBD diagnosis was confirmed by positive histology and lymphocyte proliferation test in all cases. All patients presented with signs of extrapulmonary organ involvement, including hepatic, gastric, neurologic, splenic, ocular, cutaneous, as well as possible cardiac and renal involvement.
This series underscores the importance of including CBD in the differential diagnosis of sarcoidosis in workers with possible beryllium exposure, even in the presence of extrapulmonary manifestations. Clinicians should maintain awareness of extrapulmonary involvement in patients with CBD.

PMID:
42532832
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.